IP Library Granted Patent US 8,106,019
Granted Patent B2
US 8,106,019 · App. 11/974,527 · Granted Jan 31, 2012

CHEC-7 a novel sPLA2 inhibitor

Assignee: Philadelphia Health & Education Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,106,019
App. No.
11/974,527
Granted
Jan 31, 2012
Kind
B2
Abstract

The present invention relates to the discovery of a composition including a seven-amino acid peptide that promotes neuronal survival, inhibits inflammation, and is a potent inhibitor of sPL2A, and uses thereof.

Claims (8)

1. An isolated neuron survival-promoting peptide, CHEC-7, consisting of the sequence of CHEASQC (SEQ ID NO: 3).

2. A pharmaceutical preparation comprising the neuron survival-promoting peptide of claim 1 , in a biologically acceptable carrier.

3. A kit for treating a neurodegenerative disorder or inflammatory disorder in a patient comprising:

a) an isolated CHEC-7 peptide consisting of the sequence of CHEASQC (SEQ ID NO: 3);

b) a pharmaceutical excipient; and optionally

c) a vehicle for administration, such as a syringe or catheter;

and instructional material.

4. The kit of claim 3 , wherein the kit further comprises a detectable label.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 19, 2012
From: DREXEL UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029325/0414 →
Continuity (4)
Continuation In Part 10714699 · Nov 17, 2003
Provisional Application 60426536 · Nov 15, 2002
Provisional Application 60697598 · Jul 8, 2005
Related Publication 20080249027A1 · Oct 9, 2008